triazoles has been researched along with Diathesis in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Amanati, A; Badiee, P; Ghasemi, F; Haghpanah, S; Hamzavi, SS; Jafarian, H; Nematolahi, S | 1 |
| Cao, N; Zhan, B; Zhou, X | 1 |
| Hanna, GJ; Healy, MD; Hwang, C; Krystal, M; Lataillade, M; Ray, N; Whitcomb, J; Wind-Rotolo, M | 1 |
| Ammirabile, M; Casale, M; Cinque, P; Costantini, S; Di Matola, T; Filosa, A; Prossomariti, L; Ricchi, P; Spasiano, A | 1 |
| Kamei, K; Watanabe, A | 1 |
| Arribas López, JR | 1 |
| Edwards, SG; Godley, NP | 1 |
| Patterson, K; Strek, ME | 1 |
| Patterson, TF; Thompson, GR | 1 |
| Masmiquel Comas, L; Nicolau Ramis, J | 1 |
| Campos-Herrero, MI; Horcajada, I; Medina-Rivero, F; Tandón, L | 1 |
| Cornely, OA; Karthaus, M; Ullmann, AJ | 1 |
| Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G | 1 |
| Blackwood, RA; Klein, KC | 1 |
| Sellart-Altisent, M; Torres-Rodríguez, JM | 1 |
| Anaissie, EJ; Uzun, O | 1 |
| MacPhail, RC | 1 |
| Czuczwar, SJ; Janusz, W; Kleinrok, Z; Szczepanik, B | 1 |
7 review(s) available for triazoles and Diathesis
| Article | Year |
|---|---|
[Secondary effects of treatment with maraviroc and other CCR5 antagonists. Potential impact of the CCR5 blocker].
Topics: Adult; Benzoates; CCR5 Receptor Antagonists; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Comorbidity; Cyclohexanes; Diketopiperazines; Disease Susceptibility; Drug Design; env Gene Products, Human Immunodeficiency Virus; HIV Fusion Inhibitors; HIV Infections; Homozygote; Humans; Hyperlipidemias; Incidence; Infections; Maraviroc; Membrane Fusion; Neoplasms; Piperazines; Receptors, CCR5; Sequence Deletion; Spiro Compounds; Triazoles; Virus Attachment; Virus Internalization | 2008 |
Allergic bronchopulmonary aspergillosis.
Topics: Antibodies, Monoclonal; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Disease Susceptibility; Glucocorticoids; Humans; Immunoglobulin E; Lymphocyte Activation; Pyrimidines; Respiratory Function Tests; T-Lymphocytes, Helper-Inducer; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Pulmonary aspergillosis: recent advances.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Disease Susceptibility; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Opportunistic Infections; Pulmonary Aspergillosis; Triazoles | 2011 |
Endophthalmitis caused by Phialophora verrucosa: a case report and literature review of Phialophora ocular infections.
Topics: Aged; Amphotericin B; Antifungal Agents; Caspofungin; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Glaucoma; Humans; Hypertension; Intravitreal Injections; Lipopeptides; Male; Phialophora; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2012 |
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies.
Topics: Adrenal Cortex Hormones; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Clinical Trials as Topic; Disease Susceptibility; Drug Carriers; Evidence-Based Medicine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Liposomes; Mycoses; Neutropenia; Recurrence; Risk Factors; Triazoles | 2003 |
Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Clinical Trials as Topic; Disease Susceptibility; Drug Administration Routes; Hematopoietic Cell Growth Factors; Humans; Immunocompromised Host; Leukocyte Transfusion; Mycoses; Neoplasms; Neutropenia; Triazoles | 1995 |
Episodic exposures to chemicals: what relevance to chemical intolerance?
Topics: Adolescent; Adult; Aged; Animals; Carbaryl; Child; Child, Preschool; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Resistance; Environmental Pollutants; Female; Fungicides, Industrial; Genetic Variation; Humans; Infant; Infant, Newborn; Insecticides; Male; Mice; Middle Aged; Motor Activity; Multiple Chemical Sensitivity; Rats; Reference Standards; Research Design; Risk Assessment; Solvents; Toxicology; Triazoles; Xenobiotics | 2001 |
1 trial(s) available for triazoles and Diathesis
| Article | Year |
|---|---|
Prediction of virological response and assessment of resistance emergence to the HIV-1 attachment inhibitor BMS-626529 during 8-day monotherapy with its prodrug BMS-663068.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Viral; Female; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Male; Mutation, Missense; Organophosphates; Piperazines; Prodrugs; RNA, Viral; Treatment Outcome; Triazoles; Viral Load | 2013 |
10 other study(ies) available for triazoles and Diathesis
| Article | Year |
|---|---|
Impact of antifungal stewardship interventions on the susceptibility of colonized Candida species in pediatric patients with malignancy.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antimicrobial Stewardship; Candida; Caspofungin; Child; Child, Preschool; Colony Count, Microbial; Disease Susceptibility; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Triazoles | 2021 |
Nitric Oxide as a Downstream Signaling Molecule in Brassinosteroid-Mediated Virus Susceptibility to Maize Chlorotic Mottle Virus in Maize.
Topics: Brassinosteroids; Disease Susceptibility; Gene Expression Profiling; Gene Silencing; Nitric Oxide; Plant Diseases; Plant Growth Regulators; Signal Transduction; Tombusviridae; Triazoles; Zea mays | 2019 |
Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters.
Topics: Adult; Aging; Benzoates; beta-Thalassemia; Chelation Therapy; Deferasirox; Deferoxamine; Disease Susceptibility; Female; Glomerular Filtration Rate; Humans; Hyperuricemia; Incidence; Iron Chelating Agents; Iron Overload; Italy; Kidney; Male; Nephrolithiasis; Retrospective Studies; Transfusion Reaction; Triazoles; Ultrasonography | 2014 |
[Photo quiz: Deep-seated mycosis].
Topics: Adolescent; Antifungal Agents; Disease Susceptibility; Emericella; Granulomatous Disease, Chronic; Humans; Lung; Lung Diseases, Fungal; Male; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Reduction of Fusarium head blight and deoxynivalenol in wheat with early fungicide applications of prothioconazole.
Topics: Agriculture; Crops, Agricultural; Disease Susceptibility; Flour; Food Contamination; Fungicides, Industrial; Fusarium; Plant Diseases; Quality Control; Random Allocation; Seeds; Therapeutic Irrigation; Time Factors; Triazoles; Triticum | 2010 |
[The new antidiabetic agents in the firing line.... safety reasons or witch hunt?].
Topics: Animals; Breast Neoplasms; Calcitonin; Carcinoma, Medullary; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Disease Susceptibility; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Infections; Liraglutide; Pancreatitis; Pharmacovigilance; Pioglitazone; Pyrazines; Risk Assessment; Safety-Based Drug Withdrawals; Sitagliptin Phosphate; Species Specificity; Thiazolidinediones; Thyroid Neoplasms; Triazoles; Urinary Bladder Neoplasms | 2012 |
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole | 2005 |
Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
Topics: Administration, Cutaneous; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bone Marrow Transplantation; Combined Modality Therapy; Debridement; Dermatomycoses; Disease Susceptibility; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Injections, Subcutaneous; Nystatin; Postoperative Complications; Pyrimidines; Skin; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
[Bilateral proximal cellulitis and onychomycosis in both big toes due to Fusarium solani].
Topics: Antifungal Agents; Cellulitis; Ciclopirox; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Foot Dermatoses; Fusarium; Humans; Imidazoles; Immunocompetence; Itraconazole; Male; Middle Aged; Mozambique; Onychomycosis; Pyridones; Pyrimidines; Recurrence; Toes; Travel; Triazoles; Urea; Voriconazole | 2006 |
Influence of CGS 15943 A (a nonxanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock-induced seizures in mice.
Topics: Adenosine; Animals; Anticonvulsants; Disease Susceptibility; Drug Interactions; Electroshock; Epilepsy; Male; Mice; Motor Activity; Quinazolines; Triazoles | 1991 |